NAFTA and the biotechnology industry

Examines regulations for the approval of new drugs, devices, and biotechnological procedures which might be considered indirect barriers to trade under the regional trade agreement; Canada.

Saved in:
Bibliographic Details
Published in:California western law review 1996-10, Vol.33, p.31-48
Main Author: McMahon, Eileen
Format: Article
Language:English
Subjects:
Canada
Drugs
Economic relations
Export-import trade
International aspects
Legal aspects
Medical instruments and apparatus
Medical market
North American free trade agreement
Property, Intellectual
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Examines regulations for the approval of new drugs, devices, and biotechnological procedures which might be considered indirect barriers to trade under the regional trade agreement; Canada.
ISSN:0008-1639